hide-icon
Pattern illustration of a DNA helix with a blue background for the OGT corporate brand. (1)
CTA Icon

Do you have a colleague who would like to receive OGT's DNA Dispatch newsletter?

Share this link

Welcome to the latest edition of DNA Dispatch, the quarterly newsletter from OGT, your hybridization experts.

OGT launches SureSeq Myeloid Fusion Panel

OGT is pleased to introduce the SureSeq™ Myeloid Fusion Panel, expanding your ability to identify key fusion genes implicated in AML and enhancing the understanding of myeloid cancer classification and progression.

OGT launches SureSeq Myeloid Fusion Panel Image

Dive into our top hematology probes Image

Dive into our top hematology probes

Developed by scientists, for scientists, OGT understands the real-world application of our FISH portfolio.

Our CytoCell® range includes over 150 FISH probes our popular hematology FISH probes:

  • CytoCell FAST PML
  • CytoCell FAST RARα (RARA)

A complete myeloid malignancy NGS research portfolio

At OGT, we develop pioneering hybridization technology that fits seamlessly into your workflows.

Leveraging rational, expert-driven development, our SureSeq myeloid range offers enhanced detection of complex structural variants, better coverage uniformity and a clearer genetic profile of your samples.

A complete myeloid malignancy NGS research portfolio Image

What lies ahead: The future of Next Generation Sequencing Image

OGT blog

What lies ahead: The future of Next Generation Sequencing

Dive into our discussion on the development and current state of sequencing technologies, and where the future of NGS may take us.

Don’t forget…Our FAS team can be contacted online with free support advice